Jill Ohar, MD Professor of Medicine Division of Pulmonary, Critical Care, Allergy, and Immunologic Medicine Center for Genomics and Personalized Medicine Research Comprehensive Cancer Center Center for Worker Health Director, Respiratory Care Wake Forest Baptist Health Winston-Salem, NC
John J. Russell, MDDirector of Family Medicine Residency Abington Memorial Hospital Clinical Professor of Family and Community Medicine Temple University School of Medicine Philadelphia, PA
Albert Einstein CCME Reviewer Victor B. Hatcher, PhD Professor of Medicine and Biochemistry Associate Dean, CME and Research Albert Einstein College of Medicine Director of CME Director of the Office of Research and Sponsored Programs Montefiore Medical Center Bronx, NY
Chronic obstructive pulmonary disease (COPD) is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise tolerance, and chronic cough, usually with sputum production. In severe cases, there may be respiratory failure, right heart failure, or cachexia. In the United States, COPD affects more than 5% of the adult population and is the third leading cause of death. Advances in medical therapies and better disease management approaches have increased the recognition that COPD is preventable and treatable. Yet, COPD remains both underdiagnosed and undertreated in primary care settings. To reduce the health burden caused by COPD, pulmonologists and primary care clinicians need to enhance their ability to diagnose and assess COPD, to recognize and treat exacerbations promptly, to implement pulmonary rehabilitation interventions, and to effectively use long-term maintenance therapy.
The goal of this activity is to expand the ability of primary care clinicians and community pulmonologists to optimally manage COPD, ultimately improving outcomes for the many patients who suffer from it. Program Developer/Facilitator
This activity is jointly provided by Albert Einstein College of Medicine and Montefiore Medical Center, and MCM Education.
This activity has been designed for primary care and internal medicine clinicians, community pulmonologists, and other clinicians interested and involved in the treatment of patients with COPD.
Upon completion of this educational activity, the participant should be able to:
Identify patients for whom a diagnosis of COPD should be considered.
Complete a combined assessment of COPD, including symptoms, airflow limitation, and the risk of exacerbations.
Recommend interventions for patients with COPD to improve exercise capacity.
Implement evidence-based treatment recommendations for all stages of COPD.
The “Conflict of Interest Disclosure Policies” of Albert Einstein College of Medicine of Yeshiva University require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.
The Albert Einstein College of Medicine of Yeshiva University (Einstein) also require that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.
Contributors whose COIs are irresolvable are not permitted to participate in Einstein CME activities.
Dr. Ohar discloses that she has served as a consultant for CSL Behring and AstraZeneca.
Dr. Russell discloses that he has served as a consultant for Takeda Pharmaceuticals International, Inc., U.S. and Valeant Pharmaceuticals International, Inc. and on the speakers' bureau for Sanofi Pasteur.
The staff of the Center for Continuing Medical Education at Albert Einstein College of Medicine and Montefiore Medical Center and MCM Education have nothing to disclose.
ACCME ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the Requirements of the ACCME through joint providership of Albert Einstein College of Medicine of Yeshiva University, Montefiore Medical Center, and MCM Education. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
ACCME CREDIT DESIGNATION STATEMENT: Albert Einstein College of Medicine of Yeshiva University designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in each activity.
Credit is awarded to participants who score 70% or better on the post-test.
The online activity will take approximately 60 minutes to complete. Commercial Support Statements
This activity is supported by an independent educational grant from Novartis Pharmaceuticals Corporation.
Presented by Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education and MCM Education.
The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, Albert Einstein College of Medicine & Montefiore Medical Center, Center for Continuing Medical Education, MCM Education, or Novartis Corporation. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.